The Implications of Blood Transfusions for Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
Xin Yang(Clinical Research Institute), Eric D. Peterson, E. Magnus Ohman(Tarzana Treatment Centers), Matthew T. Roe(Clinical Research Institute), Karen P. Alexander(Clinical Research Institute), Anita Y. Chen(University of Rochester Medicine), Sunil V. Rao(New York University), W. Brian Gibler(University of Cincinnati), Ralph G. Brindis
Cited by 221
Related Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
Mayo Clinic Proceedings
|Mayo Clinic Proceedings|2000|2.2k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
|Journal of the American College of Cardiology|2016|1.6k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k